Please assess the completion status of the following clinical trial:

Trial Title: StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria~Subject-specific criteria:~1. Men and women aged ≥ 18 years~2. Written informed consent~3. Sufficient healthy skin identified and reserved as a donor site in the event that the StrataGraft treatment site requires autografting~4. Clinical expectation that the study donor site will heal without grafting~5. Complex skin defects of 3-49% TBSA~   * Total burn may consist of more than one area~   Treatment site-specific criteria:~6. Thermal burn(s) with intact dermal elements for which excision and autografting are clinically indicated~7. Total of both study treatment areas can be up to 2000 cm2~8. First excision and grafting of study treatment sites~9. Thermal burn(s) on the torso, arms, or legs~Exclusion Criteria~Subject-specific criteria:~1. Pregnant women~2. Prisoners~3. Subjects receiving systemic immunosuppressive therapy~4. Subjects with a known history of malignancy~5. Preadmission insulin-dependent diabetic subjects~6. Subjects with concurrent conditions that in the opinion of the investigator may compromise subject safety or study objectives~7. Expected survival of less than three months~8. Participation in the treatment group of an interventional study within 90 days prior to enrollment~   Treatment site-specific criteria:~9. Full-thickness burns~10. Chronic wounds~11. The face, head, neck, hands, feet, buttocks, and area over joints~12. Treatment sites immediately adjacent to unexcised eschar~13. Clinical or laboratory determination of infection at the anticipated treatment sites

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- StrataGraft Skin Tissue (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).